N-Acetyl-D-Glucosamine: Synthesis, Anti-inflammatory Activity, and Potential Therapeutic Applications

Exploring novel N-acetyl-D-glucosamine derivatives for advanced anti-inflammatory treatments.

Get a Quote & Sample

Key Product Advantages

Enhanced Anti-inflammatory Potency

BNAG1, a newly synthesized derivative, shows superior inhibitory effects on inflammatory cytokines like IL-6 and TNF-α compared to parent NAG, making it a promising candidate for targeted inflammation treatments.

Reduced Leukocyte Migration

The product effectively reduces leukocyte infiltration in both lung and peritoneal cavities in LPS-challenged mice, indicating a significant role in managing inflammatory cell trafficking.

Dual In Vivo and In Vitro Efficacy

The anti-inflammatory properties of these N-acetyl-D-glucosamine derivatives have been validated through both animal models and cell culture studies, providing robust evidence of their therapeutic potential.

Key Applications

Inflammatory Disease Treatment

Explore the potential of N-acetyl-D-glucosamine derivatives in treating various inflammation-related diseases, leveraging their ability to suppress key inflammatory mediators.

Biomedical Drug Development

Utilize these advanced NAG compounds as a basis for developing next-generation biochemical drugs targeting complex inflammatory pathways.

Nutraceutical and Food Additives

Consider the application of N-acetyl-D-glucosamine as a functional food ingredient or antioxidant, with its derivatives offering enhanced benefits.

Pharmaceutical Intermediates

Serve as crucial pharmaceutical intermediates in the synthesis of more complex therapeutic agents aimed at immune system modulation and disease management.